Trust Size
$49M
What Happened
Clarus Therapeutics Holdings, Inc. filed its S-1 registration in 2020. The company was delisted from exchanges with 236 SEC filings on record.
Clarus Therapeutics Holdings, Inc. entered the SPAC market in 2020 with its initial S-1 filing with the SEC, joining the wave of blank check companies seeking acquisition targets.
SEC records show 236 total filings, including annual (10-K) and quarterly (10-Q) financial reports.
The company's last SEC filing was 2023-03-06, and it appears to have been delisted from exchanges â a common fate for SPACs that fail to meet listing requirements or generate sufficient shareholder interest.
The company was incorporated in Delaware, the preferred jurisdiction for the vast majority of SPACs due to its business-friendly legal framework.
Timeline
2020-11-30
S-1 Registration Filed
2023-03-06
Last SEC Filing
SEC Filing Details
CIK Number
1817944
Total SEC Filings
236
State of Incorporation
DE
Last Filing Date
2023-03-06
Business Location
Greenwich, CT
Trust/Asset Size
$49M
Data sourced from SEC EDGAR Company Facts API and EFTS search index.
ð SEC Filings
View all EDGAR filings for Clarus Therapeutics Holdings